Nebraska Methodist Cancer Center

Omaha, Nebraska 68114

We've found

1 trials

at this facility

A Study of Olaratumab (LY3012207) in Participants With Advanced Soft Tissue Sarcoma

Status: Enrolling, Phase I, II
Updated: 12/31/1969

from

Omaha, NE

Use our guide to learn which trials are right for you!